| NCT03233074 |
Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors |
https://ClinicalTrials.gov/show/NCT03233074 |
Recruiting |
Institut de Cancérologie de la Loire |
2020-09-30 |
| NCT04454580 |
Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy |
https://ClinicalTrials.gov/show/NCT04454580 |
Recruiting |
Ospedale Maggiore Di Trieste |
2020-07-23 |
| NCT03311815 |
Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia. |
https://ClinicalTrials.gov/show/NCT03311815 |
Recruiting |
PETHEMA Foundation |
2020-09-30 |
| NCT03284593 |
Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition |
https://ClinicalTrials.gov/show/NCT03284593 |
Active, not recruiting |
University Hospital, Toulouse |
2030-12-31 |
| NCT03262974 |
Effect of Pharmacogenetics on Imatinib Plasma Level and Response |
https://ClinicalTrials.gov/show/NCT03262974 |
Active, not recruiting |
Assiut University |
2021-05-31 |
| NCT03075969 |
Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03075969 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2019-03-16 |
| NCT03047083 |
Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review |
https://ClinicalTrials.gov/show/NCT03047083 |
Completed |
Astellas Pharma Inc |
2017-05-19 |
| NCT03045120 |
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States |
https://ClinicalTrials.gov/show/NCT03045120 |
Recruiting |
Bristol-Myers Squibb |
2021-01-31 |
| NCT02977312 |
Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan |
https://ClinicalTrials.gov/show/NCT02977312 |
Completed |
Hikma Pharmaceuticals LLC |
2015-02-28 |
| NCT02927106 |
Beat AML Core Study |
https://ClinicalTrials.gov/show/NCT02927106 |
Recruiting |
University of Florida |
2024-02-15 |
| NCT02921815 |
A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment |
https://ClinicalTrials.gov/show/NCT02921815 |
Active, not recruiting |
Celgene |
2020-06-19 |
| NCT02900430 |
Invasives Aspergillosis in Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02900430 |
Completed |
University Hospital, Brest |
2015-12-31 |
| NCT02899767 |
Transfusion in Adult Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02899767 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02896829 |
Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02896829 |
Completed |
University Hospital, Bordeaux |
2019-04-30 |
| NCT02895542 |
Preparatory Work to Assess Adherence to Oral Chemotherapy |
https://ClinicalTrials.gov/show/NCT02895542 |
Completed |
Wake Forest University Health Sciences |
2017-04-28 |
| NCT02891551 |
An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands |
https://ClinicalTrials.gov/show/NCT02891551 |
Completed |
Celgene |
2016-06-30 |
| NCT02869256 |
Regional Central Database Recording of Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02869256 |
Recruiting |
Institut Bergonié |
2024-01-31 |
| NCT02844257 |
Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia |
https://ClinicalTrials.gov/show/NCT02844257 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02844218 |
Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02844218 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02845232 |
Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly |
https://ClinicalTrials.gov/show/NCT02845232 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02842229 |
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms |
https://ClinicalTrials.gov/show/NCT02842229 |
Completed |
Celgene |
2017-02-02 |
| NCT02842112 |
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02842112 |
Completed |
Hospices Civils de Lyon |
2013-12-31 |
| NCT02774850 |
Home Away From Home - Medical Outcomes |
https://ClinicalTrials.gov/show/NCT02774850 |
Completed |
Children’s Hospital of Philadelphia |
2019-07-26 |
| NCT02777021 |
Home Away From Home - Quality of Life Surveys |
https://ClinicalTrials.gov/show/NCT02777021 |
Completed |
Children’s Hospital of Philadelphia |
2019-07-18 |
| NCT02767388 |
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery |
https://ClinicalTrials.gov/show/NCT02767388 |
Completed |
University of Nebraska |
2017-12-11 |
| NCT02759822 |
Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias |
https://ClinicalTrials.gov/show/NCT02759822 |
Recruiting |
Instituto Nacional de Cancer, Brazil |
2021-04-30 |
| NCT02734823 |
Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor |
https://ClinicalTrials.gov/show/NCT02734823 |
Recruiting |
University of Southern California |
2020-03-01 |
| NCT02714790 |
Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02714790 |
Completed |
Azienda Ospedaliera Città della Salute e della Scienza di Torino |
2015-06-30 |
| NCT02667093 |
Samples From Leukemia Patients and Their Donors to Identify Specific Antigens |
https://ClinicalTrials.gov/show/NCT02667093 |
Active, not recruiting |
PersImmune, Inc |
2020-12-31 |
| NCT02662920 |
Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML) |
https://ClinicalTrials.gov/show/NCT02662920 |
Completed |
Wake Forest University Health Sciences |
2014-04-30 |
| NCT00559065 |
A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China |
https://ClinicalTrials.gov/show/NCT00559065 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01351545 |
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) |
https://ClinicalTrials.gov/show/NCT01351545 |
Recruiting |
Center for International Blood and Marrow Transplant Research |
2021-10-31 |
| NCT02546375 |
A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands |
https://ClinicalTrials.gov/show/NCT02546375 |
Completed |
Pfizer |
2017-01-16 |
| NCT02527447 |
Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15) |
https://ClinicalTrials.gov/show/NCT02527447 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-05-10 |
| NCT02501330 |
Safety And Efficacy Of Bosutinib |
https://ClinicalTrials.gov/show/NCT02501330 |
Recruiting |
Pfizer |
2023-09-04 |
| NCT02448095 |
Retrospective Evaluation of CML Patients in the National Compassionate Program |
https://ClinicalTrials.gov/show/NCT02448095 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT02389972 |
Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study |
https://ClinicalTrials.gov/show/NCT02389972 |
Completed |
Bristol-Myers Squibb |
2017-07-13 |
| NCT02348957 |
Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib |
https://ClinicalTrials.gov/show/NCT02348957 |
Completed |
Onco Medical Consult GmbH |
2019-03-31 |
| NCT02338479 |
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02338479 |
Active, not recruiting |
Center for International Blood and Marrow Transplant Research |
2020-02-29 |
| NCT02269267 |
The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) |
https://ClinicalTrials.gov/show/NCT02269267 |
Active, not recruiting |
Medical College of Wisconsin |
2020-09-30 |
| NCT02222272 |
Effect of 2nd Gen TKI in CML |
https://ClinicalTrials.gov/show/NCT02222272 |
Completed |
European Group for Blood and Marrow Transplantation |
2014-03-19 |
| NCT02164903 |
LEONIDAS: Quality of Life Study in Chronic Myeloid Leukemia Patients |
https://ClinicalTrials.gov/show/NCT02164903 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2017-01-25 |
| NCT02161978 |
Vascular Dysfunction and Antiangiogenic Therapy |
https://ClinicalTrials.gov/show/NCT02161978 |
Completed |
University Hospital, Angers |
2018-12-12 |
| NCT01311258 |
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01311258 |
Recruiting |
University of Rochester |
2020-08-31 |
| NCT01298414 |
Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01298414 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01290107 |
Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01290107 |
Completed |
Children’s Oncology Group |
2015-01-31 |
| NCT01278069 |
PET-CT in AML for Detection of Extramedullary AML Manifestations |
https://ClinicalTrials.gov/show/NCT01278069 |
Completed |
Technische Universität Dresden |
2013-09-30 |
| NCT02016833 |
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity |
https://ClinicalTrials.gov/show/NCT02016833 |
Completed |
PX Biosolutions |
2014-06-30 |
| NCT01999556 |
LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT01999556 |
Recruiting |
Atrium Health |
2021-09-30 |
| NCT01976442 |
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia |
https://ClinicalTrials.gov/show/NCT01976442 |
Completed |
University of Rochester |
2016-11-30 |
| NCT01929408 |
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients |
https://ClinicalTrials.gov/show/NCT01929408 |
Completed |
Fred Hutchinson Cancer Research Center |
2018-12-04 |
| NCT04337138 |
A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World |
https://ClinicalTrials.gov/show/NCT04337138 |
Active, not recruiting |
Pfizer |
2020-07-31 |
| NCT01860456 |
TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study |
https://ClinicalTrials.gov/show/NCT01860456 |
Active, not recruiting |
University of Pisa |
2021-05-31 |
| NCT01805843 |
Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01805843 |
Completed |
Medical University of Graz |
2015-06-30 |
| NCT01752062 |
Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors |
https://ClinicalTrials.gov/show/NCT01752062 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01699217 |
Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase |
https://ClinicalTrials.gov/show/NCT01699217 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2019-11-30 |
| NCT01642121 |
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01642121 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01608204 |
Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01608204 |
Completed |
Rambam Health Care Campus |
2011-12-31 |
| NCT01595295 |
Registry on Hypomethylating Agents in Myeloid Neoplasms |
https://ClinicalTrials.gov/show/NCT01595295 |
Recruiting |
Arbeitsgemeinschaft medikamentoese Tumortherapie |
2020-06-30 |
| NCT01576185 |
Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01576185 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01537159 |
MRI Assessment of Leukemia Response to Therapy |
https://ClinicalTrials.gov/show/NCT01537159 |
Completed |
OHSU Knight Cancer Institute |
2018-12-31 |
| NCT01511575 |
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder |
https://ClinicalTrials.gov/show/NCT01511575 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01507441 |
Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial |
https://ClinicalTrials.gov/show/NCT01507441 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01490853 |
Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy |
https://ClinicalTrials.gov/show/NCT01490853 |
Completed |
Università degli Studi di Brescia |
2012-01-31 |
| NCT01475110 |
Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib |
https://ClinicalTrials.gov/show/NCT01475110 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01437202 |
Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01437202 |
Completed |
Asan Medical Center |
2012-09-30 |
| NCT01407757 |
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 |
https://ClinicalTrials.gov/show/NCT01407757 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01394666 |
Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML) |
https://ClinicalTrials.gov/show/NCT01394666 |
Completed |
Bristol-Myers Squibb |
2012-12-31 |
| NCT01385787 |
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01385787 |
Completed |
Center for International Blood and Marrow Transplant Research |
2017-05-31 |
| NCT01385150 |
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01385150 |
Completed |
Eastern Cooperative Oncology Group |
2012-02-03 |
| NCT04446741 |
Molecular Diagnostic Platform for AML |
https://ClinicalTrials.gov/show/NCT04446741 |
Recruiting |
PETHEMA Foundation |
2022-10-31 |
| NCT04380441 |
Quality of Life Model for Older Patients With AML |
https://ClinicalTrials.gov/show/NCT04380441 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2022-05-31 |
| NCT04369287 |
Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT04369287 |
Recruiting |
Istituto Clinico Humanitas |
2020-10-15 |
| NCT04296214 |
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT04296214 |
Recruiting |
Grupo Cooperativo de HemopatÃas Malignas |
2021-12-31 |
| NCT04259372 |
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients |
https://ClinicalTrials.gov/show/NCT04259372 |
Completed |
University of Freiburg |
2019-12-31 |
| NCT04253314 |
A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation |
https://ClinicalTrials.gov/show/NCT04253314 |
Recruiting |
AbbVie |
2023-10-17 |
| NCT04150471 |
Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients |
https://ClinicalTrials.gov/show/NCT04150471 |
Recruiting |
Seoul St. Mary’s Hospital |
2020-12-30 |
| NCT04104035 |
Leukemic Stem Cell Detection for Chronic Myeloid Leukemia Patients With Major Molecular Response |
https://ClinicalTrials.gov/show/NCT04104035 |
Recruiting |
Ankara University |
2021-01-31 |
| NCT04089839 |
A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting |
https://ClinicalTrials.gov/show/NCT04089839 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-10-31 |
| NCT04048564 |
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®) |
https://ClinicalTrials.gov/show/NCT04048564 |
Recruiting |
Incyte Corporation |
2022-02-28 |
| NCT04024241 |
Medium Dose of Cytarabine and Mitoxantrone |
https://ClinicalTrials.gov/show/NCT04024241 |
Recruiting |
Shenzhen People’s Hospital |
2019-08-31 |
| NCT03987958 |
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study) |
https://ClinicalTrials.gov/show/NCT03987958 |
Recruiting |
AbbVie |
2023-07-01 |
| NCT03933852 |
Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose |
https://ClinicalTrials.gov/show/NCT03933852 |
Recruiting |
University of Jena |
2022-12-31 |
| NCT03921047 |
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03921047 |
Recruiting |
University of Southern California |
2022-02-01 |
| NCT03918655 |
MIF Involvement in AML |
https://ClinicalTrials.gov/show/NCT03918655 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2022-10-31 |
| NCT03894852 |
SRSF2 Gene Mutation in Patients With t-MDS/AML |
https://ClinicalTrials.gov/show/NCT03894852 |
Completed |
Assiut University |
2019-12-29 |
| NCT03885076 |
Gamma Delta T Cells in AML |
https://ClinicalTrials.gov/show/NCT03885076 |
Recruiting |
Royal Marsden NHS Foundation Trust |
2020-03-31 |
| NCT03885830 |
Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients |
https://ClinicalTrials.gov/show/NCT03885830 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-12-31 |
| NCT03881826 |
Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03881826 |
Recruiting |
Université Catholique de Louvain |
2020-05-31 |
| NCT03789981 |
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03789981 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2021-12-31 |
| NCT03755856 |
Long-term Outcomes for Acute Myeloid Leukemia Patients |
https://ClinicalTrials.gov/show/NCT03755856 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2021-06-30 |
| NCT03728699 |
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy |
https://ClinicalTrials.gov/show/NCT03728699 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2025-02-28 |
| NCT03719183 |
Comparison of Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional Cytogenetic Analysis in AML |
https://ClinicalTrials.gov/show/NCT03719183 |
Enrolling by invitation |
Assiut University |
2020-12-31 |
| NCT03678454 |
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium |
https://ClinicalTrials.gov/show/NCT03678454 |
Recruiting |
Incyte Corporation |
2022-03-31 |
| NCT03600558 |
Efficacy of FLAG Regimen for the Treatment of Patients With AML |
https://ClinicalTrials.gov/show/NCT03600558 |
Recruiting |
Tianjin Medical University General Hospital |
2020-07-31 |
| NCT03540654 |
Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach |
https://ClinicalTrials.gov/show/NCT03540654 |
Completed |
University Hospital, Bordeaux |
2018-10-31 |
| NCT03537560 |
Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML |
https://ClinicalTrials.gov/show/NCT03537560 |
Enrolling by invitation |
Chang Gung Memorial Hospital |
2019-09-30 |
| NCT03526926 |
A Post-Marketing Observational Study of VYXEOSâ„¢ |
https://ClinicalTrials.gov/show/NCT03526926 |
Active, not recruiting |
Jazz Pharmaceuticals |
2020-01-31 |
| NCT03488862 |
Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients |
https://ClinicalTrials.gov/show/NCT03488862 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-10-01 |
| NCT03481868 |
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors |
https://ClinicalTrials.gov/show/NCT03481868 |
Recruiting |
University Hospital, Clermont-Ferrand |
2021-02-10 |
| NCT03454503 |
Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt |
https://ClinicalTrials.gov/show/NCT03454503 |
Active, not recruiting |
Hikma Pharmaceuticals LLC |
2021-01-31 |
| NCT03450512 |
Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive Therapy |
https://ClinicalTrials.gov/show/NCT03450512 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2022-12-01 |
| NCT03449745 |
Immune Checkpoint Receptors in AML-Leukemic Initiating Cells |
https://ClinicalTrials.gov/show/NCT03449745 |
Recruiting |
University Hospital, Bordeaux |
2021-03-31 |
| NCT03435341 |
Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain |
https://ClinicalTrials.gov/show/NCT03435341 |
Active, not recruiting |
Celgene |
2020-02-28 |
| NCT03433521 |
Observational Study of Spatio-Temporal Patterns of New Cases of Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03433521 |
Completed |
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz |
2019-01-15 |
| NCT03422731 |
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy |
https://ClinicalTrials.gov/show/NCT03422731 |
Recruiting |
City of Hope Medical Center |
2023-02-06 |
| NCT03421626 |
Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) |
https://ClinicalTrials.gov/show/NCT03421626 |
Completed |
Cepheid |
2018-08-20 |
| NCT01252589 |
Patient Reported Outcomes in Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01252589 |
Completed |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2013-09-30 |
| NCT01252485 |
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project |
https://ClinicalTrials.gov/show/NCT01252485 |
Recruiting |
University of Ulm |
NA |
| NCT01247584 |
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01247584 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01244750 |
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting |
https://ClinicalTrials.gov/show/NCT01244750 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-01-30 |
| NCT01215487 |
A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib |
https://ClinicalTrials.gov/show/NCT01215487 |
Recruiting |
University of British Columbia |
2022-01-31 |
| NCT01203033 |
Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP) |
https://ClinicalTrials.gov/show/NCT01203033 |
Completed |
West Virginia University |
2012-09-30 |
| NCT01199562 |
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01199562 |
Completed |
City of Hope Medical Center |
2013-12-31 |
| NCT01188278 |
Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey |
https://ClinicalTrials.gov/show/NCT01188278 |
Completed |
Bristol-Myers Squibb |
2013-01-31 |
| NCT01150058 |
Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01150058 |
Completed |
Children’s Oncology Group |
2012-11-30 |
| NCT01146223 |
Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01146223 |
Completed |
Children’s Oncology Group |
2011-06-30 |
| NCT01144793 |
Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias |
https://ClinicalTrials.gov/show/NCT01144793 |
Completed |
Stanford University |
2008-06-30 |
| NCT01146210 |
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01146210 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01139333 |
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01139333 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01076569 |
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01076569 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01059734 |
S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01059734 |
Completed |
Southwest Oncology Group |
2012-06-30 |
| NCT01057199 |
Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01057199 |
Completed |
Children’s Oncology Group |
2010-06-30 |
| NCT01046305 |
Symptom Burden in Chronic Myeloid Leukemia (CML) |
https://ClinicalTrials.gov/show/NCT01046305 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT01034839 |
High-dose Cytarabine and Survival in AML |
https://ClinicalTrials.gov/show/NCT01034839 |
Completed |
University of Sao Paulo General Hospital |
2008-12-31 |
| NCT01024127 |
Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01024127 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01004965 |
Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720 |
https://ClinicalTrials.gov/show/NCT01004965 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2011-01-31 |
| NCT00969891 |
Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00969891 |
Completed |
University of Copenhagen |
NA |
| NCT00898755 |
Collecting and Storing Tissue From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898755 |
Completed |
Children’s Oncology Group |
2008-07-17 |
| NCT00898092 |
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00898092 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2012-12-31 |
| NCT00898456 |
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00898456 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |
| NCT00898079 |
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898079 |
Completed |
Children’s Oncology Group |
2018-06-30 |
| NCT00896701 |
Relationship Between Natural Killer Cells’ Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 |
https://ClinicalTrials.gov/show/NCT00896701 |
Completed |
Alliance for Clinical Trials in Oncology |
2014-04-30 |
| NCT00896129 |
Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy |
https://ClinicalTrials.gov/show/NCT00896129 |
Completed |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2010-12-31 |
| NCT03647215 |
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey |
https://ClinicalTrials.gov/show/NCT03647215 |
Recruiting |
Incyte Corporation |
2020-06-30 |
| NCT04070807 |
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2 |
https://ClinicalTrials.gov/show/NCT04070807 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2020-12-31 |
| NCT00900224 |
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00900224 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2015-12-31 |
| NCT03350152 |
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience. |
https://ClinicalTrials.gov/show/NCT03350152 |
Completed |
Hospices Civils de Lyon |
2014-06-01 |
| NCT00816114 |
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial |
https://ClinicalTrials.gov/show/NCT00816114 |
Recruiting |
M.D. Anderson Cancer Center |
2020-06-30 |
| NCT00806325 |
Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00806325 |
Completed |
Ohio State University |
2010-02-28 |
| NCT03165851 |
Efficacy Analysis of Comparison of CAMS（Chinese Academy of Medical Sciences）-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03165851 |
Completed |
Institute of Hematology & Blood Diseases Hospital |
2012-12-31 |
| NCT02856204 |
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02856204 |
Completed |
Stanford University |
2017-12-31 |
| NCT02581917 |
Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02581917 |
Recruiting |
Wake Forest University Health Sciences |
2020-09-30 |
| NCT01761890 |
Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib |
https://ClinicalTrials.gov/show/NCT01761890 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01688011 |
Connect® MDS/AML Disease Registry |
https://ClinicalTrials.gov/show/NCT01688011 |
Recruiting |
Celgene |
2022-12-12 |
| NCT03526666 |
Ascorbic Acid Levels in MDS, AML, and CMML Patients |
https://ClinicalTrials.gov/show/NCT03526666 |
Completed |
Van Andel Research Institute |
2018-10-31 |
| NCT00947830 |
Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00947830 |
Completed |
McMaster University |
2012-04-30 |
| NCT00632255 |
Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment |
https://ClinicalTrials.gov/show/NCT00632255 |
Completed |
Imperial College London |
2009-05-31 |
| NCT00525746 |
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) |
https://ClinicalTrials.gov/show/NCT00525746 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2025-03-31 |
| NCT00513175 |
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00513175 |
Completed |
University of California, San Francisco |
NA |
| NCT00502983 |
Molecular Epidemiology of Acute Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT00502983 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-09-30 |
| NCT00504920 |
Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients |
https://ClinicalTrials.gov/show/NCT00504920 |
Completed |
M.D. Anderson Cancer Center |
2008-09-30 |
| NCT00459524 |
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT00459524 |
Completed |
M.D. Anderson Cancer Center |
2009-03-31 |
| NCT00429910 |
Natural History Study of Patients With Chronic Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT00429910 |
Completed |
Dana-Farber Cancer Institute |
2005-09-30 |
| NCT00390715 |
Treatment of Acute Myeloblastic Leukemia in Younger Patients |
https://ClinicalTrials.gov/show/NCT00390715 |
Completed |
PETHEMA Foundation |
2007-12-31 |
| NCT00339664 |
Analyses of Human Samples Collected in Clinical Trials |
https://ClinicalTrials.gov/show/NCT00339664 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-03-17 |
| NCT00286845 |
Use of the MiCK Assay for Apoptosis in AML |
https://ClinicalTrials.gov/show/NCT00286845 |
Completed |
Pierian Biosciences |
NA |
| NCT00257647 |
Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML) |
https://ClinicalTrials.gov/show/NCT00257647 |
Completed |
Hadassah Medical Organization |
NA |
| NCT00003931 |
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00003931 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-06-30 |
| NCT00015587 |
Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) |
https://ClinicalTrials.gov/show/NCT00015587 |
Completed |
National Institute of Environmental Health Sciences (NIEHS) |
2016-07-31 |